OICHARTS
8 AMThe 8 AM report →

TORNTPHARM

Torrent Pharmaceuticals Limited · NSE · INE685A01028 · F&O · lot 125 · 272 sessions on record
₹4,767.30▼ −32.70 · −0.7%from ₹4,800.00 the session before · 1 Oct 2026 close · NSE end of day
Open
₹4,800.00
High
₹4,810.50
Low
₹4,717.30
Day's range
₹931.9% of the previous close
VWAP
₹4,773.15close −0.12% from it
Volume, shares
3.6 L1.01× the 20-session average
Turnover, ₹ crore
170
Trades
46,0007.9 shares per trade
Previous close
₹4,800.00−32.70 to the close
Price band, next session
₹4,290.55 – ₹5,244.0510% either side of the close · dynamic, widened in 5% steps when hit
Day range54% of the way up
₹4,717.30₹4,810.50
52-week range73% of the way up
₹3,480.60 14 Oct₹5,250.00 3 Aug

−9.2% from the high · +37% from the low

The desk read · 1 Octexpiry 27 Oct · 26 days
short build-up
futures read
price −0.7% · OI +0.3%
+35.60
futures premium, ₹
+0.8% to spot ₹4,767.30
0.80
puts per call, by OI
by volume 1.34
4,800
max pain
+0.69% from the close
▲ +0.3%
futures OI on the day
+76 lots · 29,000 open

Short build-up into a 26-day expiry: futures OI +0.3% on a −0.7% day, the most call OI sits at 5,000, the most put OI at 4,500, max pain 4,800.

Futures and options

1 Oct close · lot 125 · NSE end of day

TORNTPHARM futures closed at ₹4,802.90, +0.8% to spot, with 89% of open interest in the 27 Oct contract, and the 4,750 straddle prices a move of about ±4.7% by expiry.

Futures by expiryall 3 contracts NSE lists on the stock · basis against the spot close ₹4,767.30
Futures by expiry, basis against the spot close ₹4,767.30
ExpiryClose ₹Basis ₹ · %Annualised %OI lots · on the dayShare of OI %Contracts traded
27 Oct26 days₹4,802.90+35.60+0.8%+10%26,000▲ +0.2% · +60 lots891,400
23 Nov53 days₹4,834.40+67.10+1.4%+9.7%3,100▲ +0.5% · +16 lots1137
29 Dec89 days₹4,910.00+142.70+3.0%+12%1.00.0% · 0.00 lots0.000.00

11% of futures OI sits beyond the 27 Oct contract · 29 of 56 listed contracts traded · 6,600 option contracts changed hands

Options27 Oct expiry · 26 days

The 4,750 straddle closed at ₹223.55 (call 138.25 + put 85.30), pricing a move of about ±4.7% by the 27 Oct expiry. In the last 253 windows of 19 sessions, TORNTPHARM moved more than that 86 times.

Call OI, lots
2,3002.8 L shares
Put OI, lots
1,8002.3 L shares
Puts per call, by OI
0.80by volume 1.34
Max pain
4,800+0.69% from the close
Contracts traded
29 of 56listed for this expiry
Open interest by strike, lotstop three strikes each side
Calls
Strike
Puts
460
5,000
380
4,900
270
330
4,800
4,700
360
4,500
390
Open interest added on the day, lotsthree largest additions each side
Calls
Strike
Puts
+64
5,200
+31
4,900
+110
4,800
4,750
+110
4,600
+56
4,500
+300
Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close
272 sessions on file · from 28 Aug
TORNTPHARM close and futures open interest over the last 126 sessions, with Nifty 50 rebased to the first close398746005214axis spans 31%Nifty 50TORNTPHARM1 Apr6 Jul1 OctFutures open interest, lotspeak 46,000126 sessions from 1 Apr to 1 Oct; the price axis spans 31 percent.

The market after the news

close against the last close before each bulletin · Nifty 50 over the same sessions

After the last 8 bulletins, TORNTPHARM closed higher five sessions later in 6 of 8.

Close after each bulletin on the day, one session later and five sessions later, with Nifty 50 and futures open interest
BulletinDay of the news1 session later5 sessions laterFutures OI on the day
9 JulTorrent Pharma completes merger with J.B. Chemicals▲ +0.1%Nifty +1.0% · −0.9 pp▲ +1.1%Nifty +1.0% · 0.0 pp▼ −2.8%Nifty +1.6% · −4.3 pp▲ +5.1%long build-up
8 JulTorrent Pharma, JB Chemicals reach 52-week highs after merger approval▲ +0.7%Nifty +0.3% · +0.3 pp▲ +0.7%Nifty +1.4% · −0.6 pp▲ +2.5%Nifty +0.8% · +1.7 pp▼ −1.4%short covering
8 JulTorrent Pharma, JB Chemicals reach 52-week highs after merger approval▲ +0.2%Nifty −2.1% · +2.3 pp▲ +0.8%Nifty −1.8% · +2.6 pp▲ +3.3%Nifty −1.3% · +4.6 pp▼ −0.9%short covering
7 JulNCLT approves Torrent Pharma-JB Chemicals merger▲ +0.2%Nifty −2.1% · +2.3 pp▲ +0.8%Nifty −1.8% · +2.6 pp▲ +3.3%Nifty −1.3% · +4.6 pp▼ −0.9%short covering
7 JulNCLT approves Torrent Pharma-JB Chemicals merger▲ +0.7%Nifty −0.1% · +0.8 pp▲ +0.9%Nifty −2.2% · +3.1 pp▲ +3.1%Nifty −1.6% · +4.7 pp▼ −5.9%short covering
23 MayTorrent Pharmaceuticals Q4 profit declines 21.9% due to acquisition costs▲ +1.9%Nifty +1.3% · +0.6 pp▼ −0.8%Nifty +0.8% · −1.6 pp▼ −3.8%Nifty −1.0% · −2.8 pp▼ −2.7%short covering
17 FebTorrent Pharma shares rise 6% to 52-week high after Q3 results▼ −0.1%Nifty +0.2% · −0.2 pp▼ −1.2%Nifty +0.5% · −1.7 pp▲ +3.2%Nifty −1.0% · +4.2 pp▼ −1.2%long unwinding
16 FebTorrent Pharma shares rise 6% to 52-week high after Q3 results▼ −0.1%Nifty +0.2% · −0.2 pp▼ −1.2%Nifty +0.5% · −1.7 pp▲ +3.2%Nifty −1.0% · +4.2 pp▼ −1.2%long unwinding
8 of 14 bulletins

Quarterly results

consolidated · latest filed 30 Jul, 05:35 pm IST · NSE filings

Revenue ₹4,921 cr, +55% on a year earlier; profit ₹566 cr, +3.3% in the Jun 2026 quarter, consolidated.

Last 8 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of TORNTPHARM on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue ₹ crRevenue YoYProfit ₹ crProfit YoYEPS ₹Market on the day
Jun 2026filed 30 Jul₹4,921 cr▲ +55%₹566 cr▲ +3.3%14.87▲ +5.2%Nifty +0.3% · +4.9 pp
Mar 2026filed 22 May · audited₹4,197 cr▲ +42%₹364 cr▼ −27%11.51▲ +1.9%Nifty +1.3% · +0.6 pp
Dec 2025filed 13 Feb₹3,303 cr▲ +18%₹635 cr▲ +26%18.77▲ +4.5%Nifty +0.8% · +3.7 pp
Sept 2025filed 7 Nov₹3,302 cr▲ +14%₹591 cr▲ +30%17.45▲ +6.6%Nifty +0.3% · +6.3 pp
Jun 2025filed 28 Jul₹3,178 cr▲ +11%₹548 cr▲ +20%16.19▲ +4.0%Nifty +0.6% · +3.4 pp
Mar 2025filed 31 Mar · audited₹2,959 cr▲ +7.8%₹498 cr▲ +11%14.71▼ −1.4%Nifty −1.5% · +0.1 pp
Dec 2024filed 24 Jan₹2,809 cr▲ +2.8%₹503 cr▲ +14%14.88▲ +2.8%Nifty −1.1% · +3.9 pp
Sept 2024filed 25 Oct₹2,889 cr▲ +8.6%₹453 cr▲ +17%13.37▼ −3.4%Nifty +0.7% · −4.0 pp
By financial yearApril to March · each year the sum of its four quarters as filed, consolidated · EPS summed across the quarters · only complete years
Financial-year results of TORNTPHARM on the consolidated basis, summed from the quarters filed
YearRevenue ₹ crRevenue YoYProfit ₹ crProfit YoYEPS ₹
FY26to Mar 2026₹13,980 cr▲ +21%₹2,138 cr▲ +12%63.92
FY25to Mar 2025₹11,516 cr▲ +7.3%₹1,911 cr▲ +15%56.47
FY24to Mar 2024₹10,728 cr—₹1,656 cr—48.94

Fundamentals

consolidated · filings to Jun 2026 · close ₹4,767.30 on 1 Oct

TORNTPHARM trades at 76 times trailing earnings against 38 for its industry, 10 times book value, revenue +33% over twelve months, a 1.6% dividend yield, market cap ₹1,80,000 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
₹1,80,000 cron 1 Oct · free float ₹71,000 cr
Price to earnings
76consolidated · four quarters to Jun 2026 · industry 38
Trailing EPS
₹62.60diluted · consolidated · four quarters to Jun 2026
Price to book
10consolidated · balance sheet to Mar 2026
Book value a share
₹462.32consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity
0.84borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity
17%trailing profit over average equity · consolidated
Dividend yield
1.6%₹76.00 a share in 365 days
Face value
₹5a share
Shares outstanding
38 cron 1 Oct
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
₹15,723 crfour quarters to Jun 2026
Revenue growth, 12 months
▲ +33%against the twelve months before
Revenue 2-year CAGR
▲ +20%trailing twelve months against the twelve months 2 years earlier · consolidated
Profit, trailing 12 months
₹2,156 crfour quarters to Jun 2026
Profit growth, 12 months
▲ +7.7%against the twelve months before
Profit 2-year CAGR
▲ +11%trailing twelve months against the twelve months 2 years earlier · consolidated
PeersBSE sub-group Pharmaceuticals · F&O stocks with filings on record · industry P/E 38, market caps over trailing profit of 13 stocks
Stocks in the BSE sub-group Pharmaceuticals with market cap, price to earnings and price to book
StockMarket cap ₹P/EP/BClose ₹
SUNPHARMASun Pharmaceutical Industries Limited4,30,000 cron 1 Oct36consolidated5.2₹1,801.00
DIVISLABDivi's Laboratories Limited2,50,000 cron 1 Oct52consolidated15₹9,249.00
TORNTPHARMTorrent Pharmaceuticals Limited1,80,000 cron 1 Oct76consolidated10₹4,767.30
ZYDUSLIFEZydus Lifesciences Limited1,10,000 cron 1 Oct26consolidated3.9₹1,145.70
CIPLACipla Limited1,10,000 cron 1 Oct32consolidated3.1₹1,344.00
LAURUSLABSLaurus Labs Limited1,10,000 cron 1 Oct85consolidated20₹1,984.00
MANKINDMankind Pharma Limited1,00,000 cron 1 Oct51consolidated6.3₹2,535.00
DRREDDYDr. Reddy's Laboratories Limited1,00,000 cron 1 Oct31consolidated2.6₹1,206.20
AUROPHARMAAurobindo Pharma Limited96,000 cron 1 Oct26consolidated2.5₹1,676.80
LUPINLupin Limited93,000 cron 1 Oct17consolidated4.1₹2,031.20
GLENMARKGlenmark Pharmaceuticals Limited66,000 cron 1 Oct37consolidated6.3₹2,331.00
ALKEMAlkem Laboratories Limited62,000 cron 1 Oct29consolidated4.3₹5,220.00
BIOCONBiocon Limited60,000 cron 1 Oct110consolidated1.6₹370.70
ABBOTINDIAAbbott India Limited57,000 cron 1 Oct——₹26,840.00
IPCALABIPCA Laboratories Limited49,000 cron 1 Oct—5.2₹1,943.20
GLANDGland Pharma Limited47,000 cron 1 Oct—4.6₹2,874.40
GLAXOGlaxoSmithKline Pharmaceuticals Limited47,000 cron 1 Oct—21₹2,771.10
AJANTPHARMAjanta Pharma Limited45,000 cron 1 Oct—9.9₹3,581.00
EMCUREEmcure Pharmaceuticals Limited37,000 cron 1 Oct—7.4₹1,944.60
WOCKPHARMAWockhardt Limited34,000 cron 1 Oct—6.4₹2,083.90
SAILIFESai Life Sciences Limited33,000 cron 1 Oct—13₹1,541.20
NEULANDLABNeuland Laboratories Limited28,000 cron 1 Oct—15₹21,505.00
RUBICONRubicon Research Limited27,000 cron 1 Oct—21₹1,630.90
PPLPHARMAPiramal Pharma Limited26,000 cron 1 Oct—3.2₹197.95
ACUTAASAcutaas Chemicals Limited26,000 cron 1 Oct—15₹3,196.50
SHILPAMEDShilpa Medicare Limited21,000 cron 1 Oct—8.0₹1,064.10
GRANULESGranules India Limited20,000 cron 1 Oct—4.0₹821.75
CAPLIPOINTCaplin Point Laboratories Limited20,000 cron 1 Oct—5.5₹2,631.90
PFIZERPfizer Limited18,000 cron 1 Oct—4.2₹3,858.90
ONESOURCEOnesource Specialty Pharma Limited17,000 cron 1 Oct—3.0₹1,508.00
COHANCECohance Lifesciences Limited17,000 cron 1 Oct—4.3₹451.30
ALIVUSAlivus Life Sciences Limited17,000 cron 1 Oct—5.1₹1,374.20
ERISEris Lifesciences Limited16,000 cron 1 Oct—4.2₹1,189.80
NATCOPHARMNatco Pharma Limited16,000 cron 1 Oct—1.8₹821.30
APLLTDAlembic Pharmaceuticals Limited16,000 cron 1 Oct—2.8₹815.25
JUBLPHARMAJubilant Pharmova Limited16,000 cron 1 Oct—2.2₹999.30
ASTRAZENAstraZeneca Pharma India Limited15,000 cron 1 Oct—17₹6,031.00
MARKSANSMarksans Pharma Limited15,000 cron 1 Oct—4.8₹325.60
CONCORDBIOConcord Biotech Limited14,000 cron 1 Oct—7.1₹1,374.10
AKUMSAkums Drugs and Pharmaceuticals Limited13,000 cron 1 Oct—3.8₹813.10
CORONACORONA Remedies Limited12,000 cron 1 Oct—17₹2,029.40
BLUEJETBlue Jet Healthcare Limited10,000 cron 1 Oct—7.5₹541.80
VIYASHViyash Scientific Limited10,000 cron 1 Oct—3.3₹231.75
STARStrides Pharma Science Limited10,000 cron 1 Oct—3.2₹1,084.80
PGHLProcter & Gamble Health Limited8,900 cron 1 Oct—17₹5,360.00
AARTIPHARMAarti Pharmalabs Limited8,800 cron 1 Oct—4.1₹968.50
SANOFICONRSanofi Consumer Healthcare India Limited8,700 cron 1 Oct—25₹3,787.20
SYMBIOTECSymbiotec Pharmalab Limited7,700 cron 1 Oct——₹1,198.00
SUPRIYASupriya Lifescience Limited7,500 cron 1 Oct—6.3₹931.00
MOREPENLABMorepen Laboratories Limited7,300 cron 1 Oct—5.9₹133.70
SANOFISanofi India Limited7,000 cron 1 Oct—8.5₹3,037.40
INNOVACAPInnova Captab Limited6,700 cron 1 Oct—6.1₹1,168.00
SPARCSun Pharma Advanced Research Company Limited6,300 cron 1 Oct—4.7₹194.15
SENORESSenores Pharmaceuticals Limited6,200 cron 1 Oct—6.4₹1,349.60
IOLCPIOL Chemicals and Pharmaceuticals Limited6,100 cron 1 Oct—3.4₹209.40
ORCHPHARMAOrchid Pharma Limited5,900 cron 1 Oct—4.6₹990.00
FDCFDC Limited5,500 cron 1 Oct—2.2₹335.90
GUJTHEMGujarat Themis Biosyn Limited5,000 cron 1 Oct——₹381.80
NOVARTINDNovartis India Limited4,900 cron 1 Oct——₹1,965.00
RPGLIFERPG Life Sciences Limited4,800 cron 1 Oct—8.0₹2,930.70
SMSPHARMASMS Pharmaceuticals Limited4,400 cron 1 Oct—5.6₹471.30
GUFICBIOGufic Biosciences Limited4,200 cron 1 Oct—6.3₹418.40
AARTIDRUGSAarti Drugs Limited3,800 cron 1 Oct—2.5₹421.00
UNICHEMLABUnichem Laboratories Limited3,800 cron 1 Oct—1.4₹535.05
KPLKwality Pharmaceuticals Limited3,700 cron 1 Oct——₹3,564.40
SOLARASolara Active Pharma Sciences Limited3,400 cron 1 Oct—2.7₹714.85
INDSWFTLABInd-Swift Laboratories Limited3,400 cron 1 Oct—2.5₹395.15
SHUKRAPHARShukra Pharmaceuticals Limited2,700 cron 1 Oct——₹61.80
HIKALHikal Limited2,700 cron 1 Oct—2.2₹218.15
VENUSREMVenus Remedies Limited2,400 cron 1 Oct—3.6₹1,796.70
DCALDishman Carbogen Amcis Limited2,400 cron 1 Oct—0.35₹150.35
INDOCOIndoco Remedies Limited2,300 cron 1 Oct—2.5₹251.75
SAIPARENTSai Parenterals Limited2,300 cron 1 Oct—4.7₹523.65
SYNCOMFSyncom Formulations (India) Limited2,300 cron 1 Oct—5.4₹23.95
FREDUNFredun Pharmaceuticals Limited2,200 cron 1 Oct——₹1,355.20
WINDLASWindlas Biotech Limited2,200 cron 1 Oct——₹1,082.40
PANACEABIOPanacea Biotec Limited2,200 cron 1 Oct—2.6₹359.05
HESTERBIOHester Biosciences Limited1,800 cron 1 Oct—4.9₹2,126.80
NGLFINENGL Fine-Chem Limited1,800 cron 1 Oct—5.5₹2,924.00
AHCLAnlon Healthcare Limited1,700 cron 1 Oct—6.8₹32.85
FERMENTAFermenta Biotech Limited1,600 cron 1 Oct——₹553.25
JAGSNPHARMJagsonpal Pharmaceuticals Limited1,500 cron 1 Oct—5.5₹231.75
AMRUTANJANAmrutanjan Health Care Limited1,500 cron 1 Oct—4.0₹513.20
KOPRANKopran Limited1,400 cron 1 Oct—2.6₹282.05
BPLPHARMABharat Parenterals Limited1,200 cron 1 Oct——₹1,720.40
LINCOLNLincoln Pharmaceuticals Limited1,200 cron 1 Oct—1.5₹582.05
BAJAJHCAREBajaj Healthcare Limited1,100 cron 1 Oct—2.0₹322.95
SIGACHISigachi Industries Limited1,100 cron 1 Oct—2.0₹28.35
THEMISMEDThemis Medicare Limited1,000 cron 1 Oct—2.6₹113.20
SGRLShree Ganesh Remedies Limited890 cron 1 Oct——₹694.25
ANUHPHRAnuh Pharma Limited860 cron 1 Oct—2.4₹85.85
ZIMLABZim Laboratories Limited740 cron 1 Oct—2.5₹137.00
WANBURYWanbury Limited690 cron 1 Oct—4.8₹198.00
ALBERTDAVDAlbert David Limited490 cron 1 Oct—1.3₹856.70
MEDICAMEQMedicamen Biotech Limited470 cron 17 Sept—1.7₹346.30
HALEOSLABSHALEOS LABS LIMITED450 cron 1 Oct—2.0₹1,490.00
JENBURPHJenburkt Pharmaceuticals Limited400 cron 1 Oct——₹915.25
AAREYDRUGSAarey Drugs & Pharmaceuticals Limited290 cron 1 Oct—2.0₹103.85
NECLIFENectar Lifesciences Limited200 cron 1 Oct—0.34₹10.25
MEDICOMedico Remedies Limited180 cron 1 Oct—2.4₹21.85
BALPHARMABal Pharma Limited170 cron 1 Oct—2.0₹105.75
BROOKSBrooks Laboratories Limited160 cron 1 Oct—1.3₹54.80
KREBSBIOKrebs Biochemicals and Industries Limited150 cron 1 Oct——₹68.05
PARNAXLABParnax Lab Limited130 cron 1 Oct——₹113.15
ALPAAlpa Laboratories Limited120 cron 1 Oct—0.67₹59.25
MAKERSLMakers Laboratories Limited110 cron 1 Oct——₹183.50
SUNLOCSunil Healthcare Limited72 cron 1 Oct——₹70.10
VINEETLABVineet Laboratories Limited69 cron 1 Oct—1.5₹35.90
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited48 cron 1 Oct—2.2₹29.30
MANGALAMMangalam Drugs And Organics Limited46 cron 1 Oct—0.45₹29.15
MEDICAPQMedi Caps Limited31 cron 17 Sept——₹24.80
ORTINGLOBEORTIN GLOBAL LIMITED12 cron 1 Oct—9.5₹14.50
AMANTAAmanta Healthcare Limited————
AMBALALSAAmbalal Sarabhai Enterprises Limited————
BAFNAPHBafna Pharmaceuticals Limited————
BLISSGVSBliss GVS Pharma Limited————
KILITCHKilitch Drugs (India) Limited————
LASALasa Supergenerics Limited————
LYKALABSLyka Labs Limited————
NATCAPSUQNatural Capsules Limited————
VALIANTLABValiant Laboratories Limited————
VIVIMEDLABVivimed Labs Limited————

Shareholding

quarter to 20 Jul · none pledged · NSE filings

Promoters hold 60.8%, foreign portfolio investors 18.0%, mutual funds 8.3% and insurance companies 2.0%, as filed for the quarter to 20 Jul.

By category, last 5 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of TORNTPHARM by category over the last 5 quarters with the change against the previous quarter
Category20 Jul30 Jun31 Mar31 Dec30 Sept
Promoters60.78▼ −7.53 pp68.310.00 pp68.310.00 pp68.310.00 pp68.31
Foreign portfolio investors17.97▲ +2.53 pp15.44▼ −0.74 pp16.18▲ +0.05 pp16.13▲ +0.21 pp15.92
Mutual funds8.27▲ +3.33 pp4.94▲ +0.49 pp4.45▼ −0.38 pp4.83▼ −0.29 pp5.12
Insurance companies2.03▼ −0.17 pp2.20▲ +0.26 pp1.94▲ +0.22 pp1.72▼ −0.17 pp1.89
Banks and financial institutions2.56▼ −0.13 pp2.69▲ +0.02 pp2.67▲ +0.07 pp2.60▲ +0.34 pp2.26
Individual investors7.04▲ +1.88 pp5.16▲ +0.92 pp4.24▲ +0.09 pp4.15▼ −0.04 pp4.19
Bodies corporate0.34▲ +0.05 pp0.29▼ −0.04 pp0.33▲ +0.03 pp0.30▼ −0.02 pp0.32
Others1.01▲ +0.04 pp0.97▼ −0.91 pp1.88▼ −0.08 pp1.96▼ −0.03 pp1.99

Corporate actions

NSE and BSE records

Nothing upcoming on record; the last was a dividend of ₹9.00 a share, ex-date 29 May 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios
Corporate actions of TORNTPHARM, upcoming first, then the most recent
Ex-dateActionAmount or ratioRecord dateSource
recent
29 May 2026dividend₹9.0029 May 2026BSE
18 Feb 2026dividend₹29.0019 Feb 2026BSE
20 Jun 2025dividend₹6.0020 Jun 2025BSE
31 Jan 2025dividend₹26.001 Feb 2025BSE
21 Jun 2024dividend₹6.0021 Jun 2024BSE
12 Feb 2024dividend₹22.0012 Feb 2024BSE
Calendaras notified to the exchange
Next results
—no board meeting notified yet
Dividends in 365 days
₹76.00a share · ex-dates inside the year
Last dividend
₹9.00ex-date 29 May 2026

Price history

272 sessions on record · to 1 Oct · NSE end of day

TORNTPHARM is −4.9% over 20 sessions against Nifty's −6.2%, 9.2% below its 52-week high, realised volatility 22% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
WindowFrom ₹TORNTPHARM %Nifty 50 %Difference pp
250 sessionssince 26 Sept₹3,560.88▲ +34%▼ −9.1%+43
120 sessionssince 9 Apr₹4,094.56▲ +16%▼ −5.7%+22
60 sessionssince 8 Jul₹4,866.58▼ −2.0%▼ −6.1%+4.1
20 sessionssince 2 Sept₹5,011.88▼ −4.9%▼ −6.2%+1.4
5 sessionssince 24 Sept₹4,928.46▼ −3.3%▼ −2.8%−0.49
1 sessionsince 30 Sept₹4,799.94▼ −0.68%▼ −0.88%+0.20
Averages of the closeclose against each average
5-session average
₹4,863.76close −2.0% from it
20-session average
₹4,898.84close −2.7% from it
50-session average
₹4,935.83close −3.4% from it
200-session average
₹4,436.22close +7.5% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹1102.3% of the close
Average day's range, 20
₹1002.2% of the close
Volume against 20 sessions
1.01×3.6 L vs 3.6 L average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
22%≈ ±1.4% a session · moved more than that on 5 of 20
Realised volatility, 60
26%≈ ±1.6% a session · moved more than that on 14 of 60
Realised volatility, 250
22%≈ ±1.4% a session · moved more than that on 65 of 250
Beta to Nifty, 60
0.14moved with Nifty on 31 of 60 sessions
Beta to Nifty, 250
0.29moved with Nifty on 134 of 250 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
8 up · 11 downof 19
Last 60 sessions
28 up · 30 downof 58
Last 250 sessions
133 up · 115 downof 248
Best session, 250
▲ +6.6%10 Nov
Worst session, 250
▼ −4.5%17 Jul

Torrent Pharmaceuticals Limited is in 22 NSE indices

all 22 indices

14 bulletins on TORNTPHARM

latest 9 Jul 2026

Beats in the coverage

Often mentioned with

July 2026

Torrent Pharma completes merger with J.B. ChemicalsTorrent Pharma has completed its merger with J.B. Chemicals, forming one of India's largest branded pharmaceutical businesses. This consolidation aims to enhance procurement efficiencies and expand research capabilities, significantly strengthening Torrent's market position.High Torrent Pharma, JB Chemicals reach 52-week highs after merger approvalTorrent Pharmaceuticals and JB Chemicals hit 52-week highs after NCLT approved their merger. Torrent closed at ₹4,856.70, while JB Chemicals reached ₹2,422.00, reflecting strong investor interest and trading volumes.High Torrent Pharma, JB Chemicals reach 52-week highs after merger approvalTorrent Pharmaceuticals and JB Chemicals hit fresh 52-week highs after the NCLT approved their merger. Torrent closed at ₹4,856.70, while JB Chemicals ended at ₹2,422.00, reflecting strong investor interest and trading volumes.High NCLT approves Torrent Pharma-JB Chemicals mergerNCLT has approved the merger of JB Chemicals with Torrent Pharmaceuticals, a key step in the consolidation of India's pharmaceutical sector. The merger will enhance Torrent's market presence following shareholder approval in April 2025.High NCLT approves Torrent Pharma-JB Chemicals mergerNCLT approved the merger of JB Chemicals with Torrent Pharmaceuticals, a key step in India's pharma consolidation. The merger follows shareholder approval in April 2025 and aims to strengthen Torrent's market presence.High

May 2026

Torrent Pharmaceuticals Q4 profit declines 21.9% due to acquisition costsTorrent Pharmaceuticals reported a 21.9% decline in Q4 profit to ₹3.89 billion, impacted by acquisition costs from J.B. Chemicals. Revenue grew 41.8% to ₹41.97 billion, but expenses rose nearly 60%, affecting overall profitability.Medium

February 2026

Torrent Pharma shares rise 6% to 52-week high after Q3 resultsTorrent Pharmaceuticals reported a 17.6% YoY revenue increase to ₹3,303 cr for Q3 FY26, with net profit rising 26.2% to ₹635 cr. Following the results, shares surged 6.05% to a 52-week high of ₹4,324.90.High Torrent Pharma shares rise 6% to 52-week high after Q3 resultsTorrent Pharmaceuticals reported Q3 revenue of ₹3,303 cr, up 17.6% YoY, and a net profit of ₹635 cr, a 26.2% increase. Shares surged 6.05% to a 52-week high of ₹4,324.90, reflecting positive market sentiment.High Torrent Pharma reports strong Q3 earnings and JB Pharma acquisitionTorrent Pharmaceuticals reported consolidated revenue of ₹3,303 cr for Q3 FY26, a 17.6% YoY increase. Net profit surged 26.2% YoY to ₹635 cr, driven by strong operational performance and the JB Pharma acquisition.High Torrent Pharma reports strong Q3 earnings and JB Pharma acquisitionTorrent Pharmaceuticals reported Q3 FY26 revenue of ₹3,303 cr, a 17.6% YoY increase, and net profit surged 26.2% to ₹635 cr. The strong results are bolstered by the JB Pharma acquisition, indicating robust operational performance.High

November 2025

Torrent Pharmaceuticals launches ₹6,843 crore open offer for J.B. ChemicalsHigh Torrent Group to invest ₹33,320 cr in ChhattisgarhHigh Torrent Group to invest ₹33,320 cr in ChhattisgarhHigh Torrent Pharma sees share price jump on strong Q2 performanceMedium

About Torrent Pharmaceuticals Limited

exchange masters as of 18 Sept 2026 · classification by BSE
Company
Torrent Pharmaceuticals Limited
Exchange
NSE · BSE 500420, group A
Listed on NSE
25 Nov 2002
Classification
Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
Index
BSE 200
Face value
₹5 a share
ISIN
INE685A01028
Sessions on record
272
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
1 Oct, 07:54 pm IST
Bulletins
14 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.